Remote, or decentralized, clinical trials allow CROs and sponsors to reduce costs, increase the speed of development, and improve participant access and data quality. But not all remote trials are the same. Learn the key considerations for deciding between a fully remote, hybrid or flexible hybrid approach.
Read up on the details – from studying intervention intensity and participant comfort to distributing investigational products securely – to determine which type of trial best suits your subject matter and gain insights into how strategic decentralization can dramatically improve efficiency and engagement.